David Platt - 31 Dec 2021 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role: CEO, Director, 10%+ Owner
Signature: /s/ David Platt
Issuer symbol: BIXT
Transactions as of: 31 Dec 2021
Net transactions value: +$47,501
Form type: 5
Filing time: 28 Jan 2022, 13:14:45 UTC
Previous filing: 18 Jan 2022
Next filing: 13 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIXT	Common	Award	$54,672	+227,800	+0.52%	$0.2400	43,666,374	15 Jan 2021	Direct
transaction	BIXT	Common	Award	$386,618	+2,973,988	+6.8%	$0.1300	46,640,362	04 Jun 2021	Direct
transaction	BIXT	Common	Gift	$441,847	-3,201,788	-6.9%	$0.1380	43,438,574	19 Nov 2021	Direct	F1
transaction	BIXT	Common	Award	$4,137	+2,068,563	+4.8%	$0.002000^*	45,507,137	03 Dec 2021	by NDPD Pharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIXT	Warrants	Award	$43,920	+122,000		$0.3600	122,000	02 May 2021	Common	122,000	$2.00	by NDPD Pharma, Inc.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares returned to Company's treasury
F2	The warrant agreement includes provisions for dilutive issuance and cash-less exercise